Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301473 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301471 Pharmaceutical composition for treating and/or preventing cancer
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301468 Anti-mn antibodies and methods of using same
11/29/2012US20120301467 Fas binding antibodies
11/29/2012US20120301466 Chemically programmable immunity
11/29/2012US20120301462 Compounds
11/29/2012US20120301461 1d05 pcsk9 antagonists
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301400 Meditopes and meditope-binding antibodies and uses thereof
11/29/2012US20120301396 Radioimmunoconjugates and uses thereof
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012US20120301394 Targeting and in vivo imaging of tumor-associated macrophages
11/29/2012CA2837184A1 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
11/29/2012CA2837169A1 Multivalent and monovalent multispecific complexes and their uses
11/29/2012CA2836873A1 Deimmunized serum-binding domains and their use for extending serum half-life
11/29/2012CA2836857A1 Cd3-binding molecules capable of binding to human and non-human cd3
11/29/2012CA2836800A1 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012CA2836649A1 Anti-cgrp compositions and use thereof
11/29/2012CA2834589A1 Method for preparing fc-containing polypeptides having improved properties
11/28/2012EP2527456A1 Transgenic porcines lacking endogenous immunoglobulin light chain
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012EP2527435A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression
11/28/2012EP2527429A2 DAC HYP compositions and methods
11/28/2012EP2527425A1 Cell culture improvements
11/28/2012EP2527371A1 Method for the treatment of glomerulonephritis
11/28/2012EP2527370A1 Compounds having resistance to soluble CEA
11/28/2012EP2527369A2 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
11/28/2012EP2527368A1 Anti-hepcidin antibodies and uses thereof
11/28/2012EP2527367A1 Production method
11/28/2012EP2527366A1 Monoclonal anti beta amyloid antibody
11/28/2012EP2527365A2 Proliferation of MUC1 expressing cells
11/28/2012EP2527364A1 Crystalline anti-human IL-12 antibodies
11/28/2012EP2527363A1 Vaccines based on targeting antigen to dcir expressed on antigen-presenting cells
11/28/2012EP2527361A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
11/28/2012EP2526970A1 Monitoring cancer stem cells
11/28/2012EP2526969A1 Monitoring cancer stem cells
11/28/2012EP2526968A2 Nogo receptor antagonists
11/28/2012EP2526967A1 Engineered anti-alpha v-integrin hybrid antibodies
11/28/2012EP2526959A1 Treatment of pulmonary disease conditions
11/28/2012EP2526118A1 Compositions and methods for treatment of ovarian cancer
11/28/2012EP2526114A1 Chromatographic method for purifying fc-containing proteins
11/28/2012EP2525832A1 Cancer stem cell markers and uses thereof
11/28/2012EP2525820A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
11/28/2012EP2525813A1 Anti-ilt5 antibodies and ilt5-binding antibody fragments
11/28/2012EP2525812A2 Anticoagulant antidotes
11/28/2012EP2463368A9 Humanized anti-amyloid-b oligomer antibody
11/28/2012CN1997394B Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
11/28/2012CN1984931B Anti-CD3 antibodies and methods of use thereof
11/28/2012CN1930184B Novel TAT complexes, and vaccines comprising them
11/28/2012CN102803968A Esophageal cancer marker
11/28/2012CN102803488A Human artificial chromosome vector
11/28/2012CN102803486A Novel protein and gene that codes therefor
11/28/2012CN102803295A Bispecific, tetravalent antigen binding proteins
11/28/2012CN102803294A Anti-ASCT2 (system ASC amino acid transporter type 2) antibody
11/28/2012CN102803293A SIGLEC 15 antibodies in treating bone loss-related disease
11/28/2012CN102796763A Preparation method and application of carp spermary bioreactor
11/28/2012CN102796754A Prokaryotic expression vector pMAL-Aroma19 of monopterus albus aromatase conserved domain, construction method and application method of prokaryotic expression vector pMAL-Aroma19
11/28/2012CN102796750A Nitrilases, nucleic acids encoding them and methods for making and using Them
11/28/2012CN102796707A Monoclonal antibody hybrid tumor cell strain KGH-R1 of broad spectrum anti-human p21Ras protein and monoclonal antibody
11/28/2012CN102796705A Dac hyp compositions and methods
11/28/2012CN102796195A Industrial production method for extracting immunoglobulins G from pig blood
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102079728B Tripolycyanamide analogue, preparation method of tripolycyanamide analogue and intermediate used in preparation method
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN101918549B Improved humanized anti-human alpha9-integrin antibody
11/28/2012CN101711281B Use of CTHRC1 in diagnosing cancer of liver
11/28/2012CN101410412B Generation of heavy-chain only antibodies in transgenic animals
11/28/2012CN101233236B Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/27/2012US8318917 Nucleic acids encoding antibodies having altered effector function and methods for making the same
11/27/2012US8318916 Human CTLA-4 antibodies and their uses
11/27/2012US8318914 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms
11/27/2012US8318912 Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide
11/27/2012US8318911 Anti-EpCAM antibody and uses thereof
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318909 Antibodies for diagnosis and treatment of blood platelet alloimmune disorders
11/27/2012US8318908 Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
11/27/2012US8318907 Fc variants with altered binding to FcRn
11/27/2012US8318906 EMP2 antibodies and their therapeutic uses
11/27/2012US8318905 Antibodies for depletion of ICOS-positive cells in vivo
11/27/2012US8318679 Trimerising module
11/27/2012US8318659 Peptide-based organic sunscreens
11/27/2012US8318472 Optimized nucleic acid sequences for the expression of VB4-845
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318421 Hepatitis-C virus testing
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318171 Neurotoxic oligomers
11/27/2012US8318170 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/27/2012US8318168 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2012US8318167 Methods and compositions for regulating iron homeostasis by modulation of BMP-6
11/27/2012US8318163 Anti-pan neuropilin antibody and binding fragments thereof
11/27/2012US8318162 Antibodies to high molecular weight melanoma associated antigen
11/27/2012US8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies
11/27/2012US8318159 Anti-IGF antibodies
11/27/2012CA2777978A1 Dac hyp compositions and methods
11/27/2012CA2658221C Anti-cd40 monoclonal antibody
11/27/2012CA2611778C Compositions and methods for the diagnosis and treatment of tumor
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 1494